A study appearing online today in Clinical Chemistry, the journal of AACC, shows for the first time that low quality commercial lab kits may be one factor hampering the progress of cancer diagnostics.
AACC welcomed more than 17,500 medical professionals to the association’s 63rd Annual Meeting and Clinical Lab Expo from July 28–August 1. This dynamic convention offered attendees five days packed with information on international trends and breaking science in laboratory medicine, as well as the chance to see new technology at the world’s largest clinical laboratory exposition and network with global leaders in the field.
NanoString is introducing an Early Access Program for nCounter Elements™, a line of General Purpose Reagents (GPRs) developed specifically to meet the needs of translational research and clinical laboratories. nCounter Elements GPRs enable researchers to independently develop multiplexed genomic assays, and then rapidly translate those assays into clinical diagnostics offered as Laboratory Developed Tests.
Singulex, Inc., first to commercialize Single Molecule Counting technology, today announced that the AACC has recognized two studies featuring Singulex’s Erenna® technology with theNACB’s Distinguished Abstract Award.
Rheonix, Inc. is entering into a joint development agreement with Life Technologies Corp. to introduce a molecular testing platform for their Applied Markets business.
The ultimate solution for multiplex assays, QuantiScientifics new A2 Micro Array System provides user-defined, high-throughput, high-performance assays utilizing DNA and antibody links.
AACC’s Pediatric Reference Range Committee (PRRC) is performing two pilot studies to establish crucial pediatric reference intervals as part of the National Children’s Study.
Mindray and MedTest jointly announced a US exclusive partnership that will greatly expand collaboration between the two organizations providing in-vitro products and services for low - mid volume clinical laboratories.
Created to help laboratory medicine trainees prepare for board examinations in the U.S. and U.K., the Question Bank is the most extensive compilation of board study questions ever collected.
Researchers from the University Medical Center Göttingen and Chronix Biomedical announce they have received a National Academy of Clinical Biochemistry Distinguished Abstract Award for their results from a pilot study which demonstrated the utility of a blood test to monitor organ transplant rejection.
Lab Tests Online, the world’s leading website for patient health literacy on laboratory testing, is pleased to announce that it has reached a major milestone—serving its 150 millionth visitor.
Selected research being presented at the 2013 AACC Annual Meeting includes new tests to detect life-threatening prostate cancer, new cystic fibrosis tests that can be measured at the point of care, and new ways to determine the safety of drugs used to treat schizophrenia and bipolar disorder.
AACC is pleased to announce the addition of a late-breaking session, The Supreme Court Decision on Human Gene Patents and Its Implications, to its scientific program at the 2013 AACC Annual Meeting & Clinical Lab Expo in Houston.
Breaking research appearing online today in Clinical Chemistry, the journal of AACC, demonstrates that a recently developed diagnostic test can detect the new strain of influenza (H7N9) currently causing an outbreak in China.
New research appearing online today in Clinical Chemistry, the journal of AACC, shows that decreased levels of vitamin D may predispose smokers to developing tobacco-related cancer. This study illustrates that simple vitamin D blood tests and supplements have the potential to improve smokers’ health.
New research appearing online today shows that cannabis can be detected in the blood of daily smokers for a month after last intake. The scientific data in this paper can provide real help in the public safety need for a drugged driving policy that reduces the number of drugged driving accidents on the road.
The Board of Directors of the American Association for Clinical Chemistry (AACC) today announced that it has appointed Janet B. Kreizman Chief Executive Officer effective April 1, 2013.
Clinical Chemistry, the journal of AACC, has published a special issue devoted to the subject of cancer. With cancer surpassing cardiovascular disease as the number one killer in the Western world, the issue provides a cutting edge update on the state of cancer research in laboratory medicine today. The issue includes nearly 50 articles covering a wide range of topics, including companion diagnostics, the modeling of cancer initiation and progression, novel cancer therapies such as chemoprevention and targeting the tumor microenvironment, and the potential of genomics and metabolomics to improve personalized cancer management.
New research appearing online today in Clinical Chemistry, the journal of AACC, shows that a handheld mobile device can check patients’ HIV status with just a finger prick, and synchronize the results in real time with electronic health records. This technology takes a step toward providing remote areas of the world with diagnostic services traditionally available only in centralized healthcare settings.
The American Association for Clinical Chemistry has announced the launch of "Young's Effects Online," offering instant access to the effects of thousands of diseases, drugs, and herbal remedies on medical lab tests.
On July 17, 2002, The American Association for Clinical Chemistry (AACC) is offering this critical and timely audioconference, providing vital information on how the new, evidence-based chronic kidney disease testing guidelines will affect laboratories and patients.
Eleftherios P. Diamandis, MD, PhD, Mount Sinai Hospital, Toronto, Ontario, Canada will discuss the latest advances in cancer testing at the American Association for Clinical Chemistry's "Lab 2005" conference, being held at the Marriott Marquis, New York, N.Y. on March 21-22.
Jimmie Valentine, PhD, using US Army sponsorship, is developing a series of urine tests for exposure to chemical agents which he will discuss at the American Association for Clinical Chemistry's conference, "Lab 2005: Your Path to the Future," March 21-22, in New York City.
The American Association for Clinical Chemistry is offering this critical conference, providing vital information regarding pharmacogenomics, on May 9-10, 2002, at the Double Tree Hotel in Philadelphia, PA.
On May 15, 2002, The American Association for Clinical Chemistry is offering this critical and timely audioconference, providing vital information on how the new, evidence-based diabetes testing guidelines will affect laboratories and patients.
On Tuesday, April 30, 2002; 2:00 pm-3:15 pm EST, The American Association for Clinical Chemistry and The American Society for Clinical Laboratory Science will provide a timely and useful audioconference on how to implement the new medical privacy standards.
The American Association for Clinical Chemistry (AACC) organized an audioconference on what clinical laboratories need to know about chemical and bioterrorism on Wednesday, December 12, 2001. The proceeds, totaling $4,000, were donated to the Salvation Army.
Our leading experts will address the most challenging issues facing the laboratory industry and share their visions with you. You will be able to invigorate your organization with new strategies that will allow you to successfully compete in today's complex and dynamic environment.
The American Association for Clinical Chemistry is offering this two-day annual conference, providing critical information on new advances in cancer detection and monitoring, on April 25-26, 2002 at the Hilton La Jolla Torrey Pines in La Jolla, CA.
A must-attend conference for all clinicians, laboratorians and other health care professionals in the field of cardiac risk assessment! Explore together the best methods of diagnosing, monitoring and managing cardiac diseases.
AACC Presents the Seventh Annual: Managing Your Point-of-Care Testing Program for Success. This practical three-part audioconference, providing critical information needed to make the right decisions on point-of-care testing, will be presented on January 23, 30, and February 6, 2002.
In the wake of recent terrorist attacks, clinical laboratories need to re-examine their preparedness for natural and terrorist disasters. This audioconference is a unique opportunity to find out what laboratories need to do meet the challenge.
In the December issue of Clinical Chemistry, investigators at Duke University and the California Department of Health Services report on a new test for newborn screening that can be performed within the time allowed for hospital stays under early discharge policies and can detect a wider range of congenital disorders.